Sign in
Taking people in FinlandPhase 2

Imaging Test for Finding Spread of Pancreatic Cancer to Lymph Nodes

Tests a PET scan using 18F-FAPI-74 to find pancreatic cancer spread in adults.

Key facts

Who runs it
Turku University Hospital
Where
Turku, FinlandSee the site
Registry title
Diagnostic Efficacy of 18F-FAPI-74 PET/CT in Patients with Pancreatic Cancer
Status
Recruiting
Phase
Phase 2
People taking part
100 people, planned
Started
9 Oct 2024
Planned end
5 Aug 2026
Type of study
Interventional
Record updated
20 August 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with pancreatic cancer, or suspected pancreatic cancer, to test how well 18F-FAPI-74 PET/CT scans find cancer spread to nearby lymph nodes.

Age
18-85 years
Sex
Men and women
Disease stage
Primary or recurrent pancreatic cancer, or suspected primary or recurrent pancreatic cancer

Main reasons for not taking part

  • Vulnerable people named in Finnish clinical study law (disabled, children, pregnant or breast-feeding women, prisoners)
  • Cannot understand the purpose of the study
  • Medical conditions that rule out whole-body PET/CT imaging

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Primary or recurrent pancreatic cancer
  • Suspected primary or recurrent pancreatic cancer
  • Male or female aged 18-85 years
  • WHO performance score 0-2
  • Study subject signs informed consent form after receiving written information

Who cannot take part

  • Medical conditions prohibiting whole-body PET/CT imaging
  • Vulnerable study subjects such as described in Finnish law clinical studies (disabled, children, pregnant or breast-feeding women, prisoners) will not be included
  • Study subject is not able to understand the purpose of the study

Where in Finland

  • Turku University HospitalTurku, FinlandTaking people

About the trial

What the trial wants to find out

To assess the accuracy of 18F-FAPI-74 PET/CT in detection of local lymph node metastasis in patient level in patients with primary pancreatic cancer.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
Diagnostic Efficacy of 18F-FAPI-74 PET/CT in Patients with Pancreatic Cancer
Plain-language title
Imaging Test for Finding Spread of Pancreatic Cancer to Lymph NodesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
20 August 2024